| Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939) |
|---|
| 07/06/2006 | US20060148850 4-{'3-(Sulfonylamino) phenyl!'1-(cyclymethyl) piperidin-4-ylidene! methyl}benazmide derivativess as delta opioid receptor ligands for the treatment of pain, anxiety and functional gastrointestinal disorder |
| 07/06/2006 | US20060148844 Pharmaceutical composition for treatment of disease due to vascular constriction or vasodilation |
| 07/06/2006 | US20060148816 17Beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases |
| 07/06/2006 | US20060148799 Substituted p-phenyl carbamates |
| 07/06/2006 | US20060148724 Genipin derivatives and uses thereof |
| 07/06/2006 | CA2594264A1 4-piperidinol tertiary amines as histamine 3 receptor inhibitors for the treatment of obesity and other cns disorders |
| 07/06/2006 | CA2591894A1 Process for producing 1-benzyl-4-[(5,6-dimethoxy-1-indanon2-yl)methyl] piperidine or its salt thereof via novel intermediate |
| 07/06/2006 | CA2587348A1 Organic compounds |
| 07/05/2006 | EP1675844A1 Phenyl carboxamide and sulfonamide derivatives for use as 11-beta-hydroxysteroid dehydrogenase |
| 07/05/2006 | EP1675812A2 Bridged ring structures as pharmaceutical agents |
| 07/05/2006 | CN1798729A Benzamide nitrile derivatives |
| 07/04/2006 | US7071231 Especially Type II diabetes; stimulating the kinase activity of the insulin receptor; activating the insulin receptor |
| 07/04/2006 | US7071214 Compounds and compositions for delivering active agents |
| 07/04/2006 | US7071213 Cannabinoid receptor ligands |
| 07/04/2006 | US7071212 N-(4-carbamimidoyl-phenyl)-glycine derivatives |
| 07/04/2006 | US7071211 Vision disorders; adjustment activation of gelatinase |
| 07/04/2006 | US7071201 Serotonin antagonism; muscle relaxant for myotonia; such as 1-(1-(2-(4-methoxyphenyl)ethyl)piperidin-4-yl)-7-methoxy-1,2,3,4 -tetrahydroquinoline |
| 07/04/2006 | US7071198 Antiinflamamtory agents; antiarthritic agents; inflammatory bowel disorders; multiple sclerosis; asthma |
| 07/04/2006 | US7071195 Especially amino- or amido-ethyltetralin derivatives |
| 07/04/2006 | US7071191 Non-imidazole aryloxypiperidines |
| 07/04/2006 | US7071175 Pyridine mercapto carboxylic acids as carboxypeptidase U inhibitors |
| 07/04/2006 | US7070626 Oxidative coloring agents for keratin fibers |
| 07/04/2006 | CA2200579C Phenyl-oxo-alkyl-(4-piperidinyl)benzoate derivatives as colon motility enhancing agents |
| 06/29/2006 | WO2006069287A1 Process for making substituted piperidines |
| 06/29/2006 | WO2006068992A1 Cycloalkyl lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 06/29/2006 | WO2006068991A1 Cycloalkyl lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 06/29/2006 | WO2006067587A2 Nonnucleoside inhibitors of hiv-1 reverse transcriptase |
| 06/29/2006 | WO2006067472A1 Parp inhibitors |
| 06/29/2006 | WO2006067401A1 Heterocyclic compounds as ccr2b antagonists |
| 06/29/2006 | WO2006067385A1 Chemical compounds |
| 06/29/2006 | WO2006067114A1 Sulfonyl amino cyclic derivatives and use thereof |
| 06/29/2006 | WO2006066948A1 Piperidine derivatives as antagonists of the cc chemokine receptor ccr1 and their use as anti-inflammatory agents |
| 06/29/2006 | WO2006066748A1 Tetralin and indane derivatives and uses thereof as 5-ht antagonists |
| 06/29/2006 | WO2006066747A1 4-aminopiperidine derivatives |
| 06/29/2006 | WO2006060390A1 Quinoline tachykinin receptor antagonists |
| 06/29/2006 | US20060142612 Arylsulfonamide derivatives |
| 06/29/2006 | US20060142594 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases |
| 06/29/2006 | US20060142583 Reacting d,l-threo alpha-aryl-2-piperidineacetamide stereoisomers with an acid resolving agent in an organic solvent to form amine salts; preferentially reacting the d-threo stereoisomer with an aqueous base followed by esterification; methylphenidate intermediates; side effect reduction |
| 06/29/2006 | US20060142342 Bicyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives |
| 06/29/2006 | US20060142341 Bicyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives |
| 06/29/2006 | US20060142338 Androgen sensitive diseases; prostate cancer; skin disorders; alopecia |
| 06/29/2006 | US20060142337 Piperidine derivative and use thereof |
| 06/29/2006 | US20060142336 N-sulfonylpiperidines as metalloproteinase inhibitors (tace) |
| 06/29/2006 | US20060142302 Chemical compounds |
| 06/29/2006 | US20060142286 Cyclic hydroxylamine as psychoactive compounds |
| 06/29/2006 | CA2592092A1 Nonnucleoside inhibitors of hiv-1 reverse transcriptase |
| 06/29/2006 | CA2591800A1 Tetralin and indane derivatives and uses thereof as 5-ht antagonists |
| 06/29/2006 | CA2591738A1 Process for making substituted piperidines |
| 06/29/2006 | CA2590957A1 4-aminopiperidine derivatives |
| 06/29/2006 | CA2589748A1 Heterocyclic compounds as ccr2b antagonists |
| 06/29/2006 | CA2589629A1 Quinoline tachykinin receptor antagonists |
| 06/29/2006 | CA2589367A1 Sulfonyl amino cyclic derivatives and use thereof |
| 06/28/2006 | EP1674452A1 Novel 4-phenylamino-benzaldoxime derivative and use thereof as mek inhibitor |
| 06/28/2006 | EP1674099A1 Therapeutic combination of amlodipine and benazepril / benazeprilat |
| 06/28/2006 | EP1673366A1 1-"2-(4-hydroxyphenyl)-2-hydroxyethyl]-piperidin-4-ol compounds as nmda receptor antagonists |
| 06/28/2006 | EP1673341A1 Tetrahydropyridine derivatives |
| 06/28/2006 | EP1673090A1 Fused-aryl and heteroaryl derivatives and methods of their use |
| 06/28/2006 | EP1673084A1 1-2' (1,4'-biperidin-1'-yl)-1-(phenyl)-ethylcyclohexanol derivatives as monoamine reuptake modulators for the treatment of vasomotor symptoms |
| 06/28/2006 | EP1673083A2 N-substituted azacycles |
| 06/28/2006 | EP1673059A2 Alkanol and cycloalkanol-amine derivatives and methods of their use |
| 06/28/2006 | EP1389188B1 Method for the production of biperiden ii |
| 06/28/2006 | EP1061922B1 Use of n-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds for treating hepatitis virus infections |
| 06/28/2006 | CN1795190A Compounds and methods for the treatment or prevention of flavivirus infections |
| 06/28/2006 | CN1795185A Process for making substituted pyrazoles |
| 06/28/2006 | CN1794989A N-(((((1,3-thiazol-2-yl)amino)carbonyl)phenyl)sulfonyl)phenylalanine derivatives and related compounds for the treatment of diabetes |
| 06/28/2006 | CN1261098C p38-alpha kinase inhibitors |
| 06/27/2006 | US7067670 Sulfamato hydroxamic acid metalloprotease inhibitor |
| 06/27/2006 | US7067665 phenylethoxy-phenyl- or -pyridyl- (acet) amides, N-substituted with pyrimidine ring-containing (tetrahydro)pyridines or phenyl groups; e.g., 3-[2-(2,4-Dichloro-phenyl)-ethoxy]-4-methoxy-N-[4-(pyrimidin-2-ylsulfamoyl)-phenyl]-benzamide; treating cardiovascular disorders such as thromboses and restenoses |
| 06/27/2006 | US7067656 Sulfamoyl compounds and agricultural and horticultural fungicides |
| 06/27/2006 | US7067541 2-amino-pyridine derivatives useful for the treatment of diseases |
| 06/27/2006 | US7067535 5-Phenylbenzylamine compounds, process for their production and intermediates for their synthesis |
| 06/27/2006 | US7067534 Melanin-concentrating hormone; N-(N'-substituted indolyl)methyl-4-(m-alkylamidophenyl) piperidine; antidepressants, anxiolytic agents; obesity, incontinence |
| 06/27/2006 | US7067533 Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereof |
| 06/27/2006 | US7067525 Compounds useful as modulators of Melanocortin Receptors and pharmaceutical compositions comprising same |
| 06/27/2006 | US7067517 Use of compounds for decreasing activity of hormone-sensitive lipase |
| 06/27/2006 | US7067516 Compounds used as antiinflammatory agents and enzyme inhibitors |
| 06/27/2006 | US7067501 Phenylsulfanylphenyl and phenyloxyphenyl substituted piperazine compounds; glycine transport inhibitors; for the treatment of psychoses and convulsive disorders: epilepsy, spasticity, and myoclonus |
| 06/22/2006 | WO2006066011A2 Compounds and compositions as modulators of steroidal receptors and calcium channel activities |
| 06/22/2006 | WO2006065659A2 Insecticidal bis(substituted phenyl)-1-{[4-(saturated heterocyclyl-substituted)phenylmethyl]-(4-piperidyl)}methane derivatives |
| 06/22/2006 | WO2006065479A2 Substituted phenols as active agents inhibiting vegf production |
| 06/22/2006 | WO2006064757A1 Aminocarboxylic acid derivative and medicinal use thereof |
| 06/22/2006 | WO2006064351A2 N-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenalin re-uptake inhibitors |
| 06/22/2006 | WO2006064221A1 Process for the preparation of n- (4-piperidinyl) -n-ethyl-phenylacetamides from n-boc-4-oxopiperidine |
| 06/22/2006 | WO2006064052A1 A process for the preparation of alpha-aryl-alpha-piperid-2-yl-acetamides and the acid hydrolysis thereof |
| 06/22/2006 | WO2006063722A1 Piperidinesulfonylureas and -thioureas, their preparation, their use and pharmaceutical compositions comprising them |
| 06/22/2006 | WO2006052555A3 Niacin receptor agonists, compositions containing such compounds and methods of treatment |
| 06/22/2006 | US20060135777 Method for the production of d-threo-2-phenyl-2-piperidine-2-yl acetates |
| 06/22/2006 | US20060135659 Having at least one sterically hindered nitroxyl, hydroxylamine or hydrocarbyloxyamine moiety and at least one conventional organohalogen or organophosphorus flame retardant moiety: 1-cyclohexyloxy-2,2,6,6-tetramethyl-4-piperidinyl diphenyl phosphate; fireproofing organic polymer substrates |
| 06/22/2006 | US20060135561 4-Aminopiperidine derivatives |
| 06/22/2006 | US20060135531 Modulators of dopamine neurotransmission |
| 06/22/2006 | US20060135505 N-(7-hydroxy-5,6,7,8-tetrahydronaphthalen-1-yl)-N'-[3-piperidin-1-yl-4-(trifluoromethyl)benzyl]urea; urinary incontinence, overactive bladder, pain, nerve injury, ischemia, neurodegeneration, stroke, inflammatory disorders, asthma and chronic obstructive pulmonary disease |
| 06/22/2006 | US20060135504 N-(substituted arylmethyl)-4-(disubstituted methyl) piperidines and pyridines |
| 06/22/2006 | US20060135503 Cyclic amide derivative as monocyte chemotactic protein modulator; prevention and treatment of rheumatoid arthritis, multiple sclerosis, atherosclerosis and asthma; antiinflammatory agents; N-[2-[[(cis) -2-[[1- (4-Chlorophenyl)ethyl]amino]cyclohexyl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide |
| 06/22/2006 | US20060135502 Cyclic derivatives as modulators of chemokine receptor activity |
| 06/22/2006 | DE102004061017A1 Piperidinsulfonylharnstoffe und -thioharnstoffe, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate Piperidinsulfonylharnstoffe and thioureas, their preparation, their use and pharmaceutical compositions containing them |
| 06/22/2006 | CA2591415A1 N-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenalin re-uptake inhibitors |
| 06/22/2006 | CA2591404A1 A process for the preparation of alpha-aryl-alpha-piperid-2-yl-acetamides and the acid hydrolysis thereof |
| 06/22/2006 | CA2591399A1 Aminocarboxylic acid derivative and medicinal use thereof |
| 06/22/2006 | CA2590405A1 Piperidinesulfonylureas and -thioureas, their preparation, their use and pharmaceutical compositions comprising them |
| 06/22/2006 | CA2590222A1 Heterocycloalkyl-benzyl substituted hydroxyethlamines |